Drawing for VRHEUM

USPTO serial 97903621

VRHEUM

Reviewed by CopyMark Law Group

Status 733Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
SPARACINO, MARK V
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 733: Status 733 means the fourth six-month extension was granted. Only one extension typically remains before you must file a Statement of Use or risk abandonment.

Need help with VRHEUM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $648*

Plus Government fees of $300

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Chidera N. Dawodu

Chidera N. Dawodu WILSON SONSINI GOODRICH & ROSATI650 PAGE MILL ROADPALO ALTO, CA 94304-1050United States

Goods and services

ClassDescriptionStatusFirst use
009Downloadable software for data collection and analysis in the fields of medical data, symptom management, disease treatment; downloadable computer software for viewing, accessing, analyzing, retrieving, processing, storing, tracking, disseminating, interpreting, and managing rheumatic disease symptoms and treating pediatric arthritis and rheumatic diseaseACTIVE—
042Scientific and medical research in the field of pediatric rheumatic disease; collecting, processing, storing, data for pediatric arthritis and rheumatic diseases symptom and treatment analysis, management and tracking; providing temporary use of non-downloadable software for viewing, accessing, analyzing, retrieving, processing, storing, tracking, disseminating, interpreting, and managing pediatric arthritis and rheumatic disease symptoms and treating pediatric arthritis and rheumatic diseases; Platform as a service (PAAS) featuring a computer software platform for scientists and medical professionals to collect, record, verify, track, analyze, disseminate, share and report data about pediatric arthritis and rheumatic disease symptoms and treatment; Providing information about scientific, medical, and biomedical research and data analysis; Providing information about medical research about pediatric arthritis and rheumatic disease, pediatric arthritis and rheumatic disease symptoms and pediatric arthritis and rheumatic disease treatmentACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 16, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 15, 2026EX4GSOU EXTENSION 4 GRANTED—
Oct 15, 2026EXT4SOU EXTENSION 4 FILED—
Oct 15, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 15, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 14, 2026EX3GSOU EXTENSION 3 GRANTED—
Apr 14, 2026EXT3SOU EXTENSION 3 FILED—
Apr 14, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 16, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 15, 2025EX2GSOU EXTENSION 2 GRANTED—
Oct 15, 2025EXT2SOU EXTENSION 2 FILED—
Oct 15, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 5, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 4, 2025EX1GSOU EXTENSION 1 GRANTED—
Apr 4, 2025EXT1SOU EXTENSION 1 FILED—
Apr 4, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 15, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 20, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 20, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 31, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 16, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 18, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 18, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 18, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 18, 2024EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Jun 18, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 18, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 18, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 29, 2024DOCKASSIGNED TO EXAMINER—
Mar 21, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 21, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 21, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 13, 2024ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Feb 6, 2024PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Jan 22, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 22, 2024DOCKASSIGNED TO EXAMINER—
May 22, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 27, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance